There are 61/216 (28.2%) PTMC patients with the excellent response (ER), 47/216 (21.6%) patients with the biochemical incomplete response (BCIR), 35/216 (16.5) patients with the structural incomplete response (SIR) and 73/216 (33.8%) patients with the indeterminate response (IR).